Yüklüyor......
Investigation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of a Long-Acting α-MSH Analog in Healthy Overweight and Obese Subjects
MC4-NN2-0453 is a novel, long-acting, selective, melanocortin-4-receptor agonist developed for treatment of obesity. This first-human-dose, randomized, double-blind, placebo-controlled trial investigated the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of...
Kaydedildi:
| Yayımlandı: | J Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BlackWell Publishing Ltd
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4263154/ https://ncbi.nlm.nih.gov/pubmed/24166760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.211 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|